AtriCure Gross Margin 2010-2025 | ATRC
Current and historical gross margin for AtriCure (ATRC) over the last 10 years. The current gross profit margin for AtriCure as of March 31, 2025 is %.
| AtriCure Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-03-31 | $0.48B | $0.36B | 75.00% |
| 2024-12-31 | $0.47B | $0.35B | 74.84% |
| 2024-09-30 | $0.45B | $0.34B | 74.78% |
| 2024-06-30 | $0.43B | $0.32B | 74.88% |
| 2024-03-31 | $0.42B | $0.31B | 75.18% |
| 2023-12-31 | $0.40B | $0.30B | 75.44% |
| 2023-09-30 | $0.38B | $0.29B | 75.26% |
| 2023-06-30 | $0.37B | $0.27B | 75.07% |
| 2023-03-31 | $0.35B | $0.26B | 74.79% |
| 2022-12-31 | $0.33B | $0.25B | 74.62% |
| 2022-09-30 | $0.32B | $0.24B | 75.00% |
| 2022-06-30 | $0.30B | $0.23B | 74.92% |
| 2022-03-31 | $0.29B | $0.22B | 75.09% |
| 2021-12-31 | $0.27B | $0.21B | 75.46% |
| 2021-09-30 | $0.26B | $0.19B | 74.81% |
| 2021-06-30 | $0.24B | $0.18B | 74.49% |
| 2021-03-31 | $0.21B | $0.16B | 72.77% |
| 2020-12-31 | $0.21B | $0.15B | 71.98% |
| 2020-09-30 | $0.21B | $0.15B | 72.38% |
| 2020-06-30 | $0.21B | $0.15B | 72.64% |
| 2020-03-31 | $0.23B | $0.17B | 73.91% |
| 2019-12-31 | $0.23B | $0.17B | 74.03% |
| 2019-09-30 | $0.22B | $0.17B | 73.99% |
| 2019-06-30 | $0.22B | $0.16B | 73.61% |
| 2019-03-31 | $0.21B | $0.15B | 73.21% |
| 2018-12-31 | $0.20B | $0.15B | 73.27% |
| 2018-09-30 | $0.20B | $0.14B | 72.82% |
| 2018-06-30 | $0.19B | $0.14B | 73.26% |
| 2018-03-31 | $0.18B | $0.13B | 73.33% |
| 2017-12-31 | $0.17B | $0.13B | 72.99% |
| 2017-09-30 | $0.17B | $0.12B | 72.78% |
| 2017-06-30 | $0.17B | $0.12B | 72.12% |
| 2017-03-31 | $0.16B | $0.12B | 71.88% |
| 2016-12-31 | $0.16B | $0.11B | 71.61% |
| 2016-09-30 | $0.15B | $0.11B | 72.00% |
| 2016-06-30 | $0.14B | $0.10B | 72.03% |
| 2016-03-31 | $0.14B | $0.10B | 71.32% |
| 2015-12-31 | $0.13B | $0.09B | 71.54% |
| 2015-09-30 | $0.12B | $0.09B | 70.73% |
| 2015-06-30 | $0.12B | $0.08B | 70.59% |
| 2015-03-31 | $0.11B | $0.08B | 70.80% |
| 2014-12-31 | $0.11B | $0.08B | 70.37% |
| 2014-09-30 | $0.10B | $0.07B | 71.29% |
| 2014-06-30 | $0.09B | $0.07B | 72.34% |
| 2014-03-31 | $0.09B | $0.06B | 73.56% |
| 2013-12-31 | $0.08B | $0.06B | 74.07% |
| 2013-09-30 | $0.08B | $0.06B | 74.03% |
| 2013-06-30 | $0.07B | $0.05B | 73.97% |
| 2013-03-31 | $0.07B | $0.05B | 73.24% |
| 2012-12-31 | $0.07B | $0.05B | 73.91% |
| 2012-09-30 | $0.07B | $0.05B | 73.53% |
| 2012-06-30 | $0.07B | $0.05B | 73.13% |
| 2012-03-31 | $0.07B | $0.05B | 72.73% |
| 2011-12-31 | $0.07B | $0.05B | 72.31% |
| 2011-09-30 | $0.06B | $0.05B | 73.44% |
| 2011-06-30 | $0.06B | $0.05B | 74.60% |
| 2011-03-31 | $0.06B | $0.05B | 76.67% |
| 2010-12-31 | $0.06B | $0.05B | 77.59% |
| 2010-09-30 | $0.06B | $0.04B | 76.79% |
| 2010-06-30 | $0.06B | $0.04B | 76.36% |
| 2010-03-31 | $0.06B | $0.04B | 76.36% |
| 2009-12-31 | $0.06B | $0.04B | 76.36% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.565B | $0.465B |
| AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $235.957B | 28.37 |
| Boston Scientific (BSX) | United States | $147.560B | 36.94 |
| Stryker (SYK) | United States | $144.011B | 30.11 |
| EssilorLuxottica (ESLOY) | France | $128.708B | 0.00 |
| Medtronic (MDT) | Ireland | $111.928B | 15.87 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.371B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.904B | 27.87 |
| ResMed (RMD) | United States | $36.560B | 27.46 |
| Agilent Technologies (A) | United States | $33.258B | 21.68 |
| GE HealthCare Technologies (GEHC) | United States | $33.082B | 15.71 |
| Terumo (TRUMY) | Japan | $26.680B | 34.65 |
| Insulet (PODD) | United States | $21.438B | 84.15 |
| Koninklijke Philips (PHG) | Netherlands | $21.384B | 15.37 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.060B | 11.60 |
| Baxter (BAX) | United States | $15.713B | 11.73 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.872B | 0.00 |
| Demant (WILYY) | Denmark | $9.377B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.175B | 21.49 |
| Lantheus Holdings (LNTH) | United States | $5.385B | 13.58 |
| Prestige Consumer Healthcare (PBH) | United States | $4.149B | 18.54 |
| Perrigo (PRGO) | Ireland | $3.664B | 9.29 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.367B | 15.34 |
| ICU Medical (ICUI) | United States | $3.250B | 23.96 |
| Envista Holdings (NVST) | United States | $3.127B | 25.99 |
| GN Store Nord (GNNDY) | Denmark | $2.263B | 18.74 |
| QuidelOrtho (QDEL) | United States | $1.954B | 13.44 |
| LeMaitre Vascular (LMAT) | United States | $1.833B | 40.97 |
| Acuren (TIC) | United States | $1.357B | 0.00 |
| Neogen (NEOG) | United States | $1.200B | 15.36 |
| AdaptHealth (AHCO) | United States | $1.161B | 11.78 |
| Green Thumb Industries (GTBIF) | United States | $1.048B | 23.58 |
| BioLife Solutions (BLFS) | United States | $1.046B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.970B | 12.40 |
| Kestra Medical Technologies (KMTS) | United States | $0.904B | 0.00 |
| InMode (INMD) | Israel | $0.844B | 8.51 |
| Evolus (EOLS) | United States | $0.640B | 0.00 |
| CeriBell (CBLL) | United States | $0.624B | 0.00 |
| Owens & Minor (OMI) | United States | $0.602B | 4.99 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.542B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.538B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.524B | 0.00 |
| Valneva SE (VALN) | France | $0.510B | 0.00 |
| Surmodics (SRDX) | United States | $0.417B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.407B | 0.00 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.337B | 12.41 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.329B | 58.50 |
| Canopy Growth (CGC) | Canada | $0.272B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.263B | 22.17 |
| Sanara MedTech (SMTI) | United States | $0.256B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.254B | 0.00 |
| ZimVie (ZIMV) | United States | $0.253B | 11.52 |
| Cerus (CERS) | United States | $0.252B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.245B | 0.00 |
| Quanterix (QTRX) | United States | $0.235B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.221B | 0.00 |
| Biote (BTMD) | United States | $0.207B | 5.82 |
| Brainsway (BWAY) | Israel | $0.206B | 54.50 |
| Omeros (OMER) | United States | $0.199B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.196B | 0.00 |
| Organigram Global (OGI) | Canada | $0.187B | 0.00 |
| High Tide (HITI) | Canada | $0.185B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.179B | 14.59 |
| Verano Holdings (VRNOF) | United States | $0.174B | 0.00 |
| Exagen (XGN) | United States | $0.152B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.140B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.131B | 0.00 |
| Jin Medical (ZJYL) | China | $0.107B | 0.00 |
| MacroGenics (MGNX) | United States | $0.096B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.64 |
| Veru (VERU) | United States | $0.090B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.087B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Agape ATP (ATPC) | $0.084B | 0.00 | |
| TerrAscend (TSNDF) | Canada | $0.075B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Apyx Medical (APYX) | United States | $0.066B | 0.00 |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 55.29 |
| United-Guardian (UG) | United States | $0.037B | 12.90 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.019B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| Safety Shot (SHOT) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| INLIF (INLF) | $0.012B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |